Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 67

1.

Prostanoid EP4 receptor-mediated augmentation of Ih currents in Aβ dorsal root ganglion neurons underlies neuropathic pain.

Zhang H, Kashihara T, Nakada T, Tanaka S, Ishida K, Fuseya S, Kawagishi H, Kiyosawa K, Kawamata M, Yamada M.

J Pharmacol Exp Ther. 2018 Nov 8. pii: jpet.118.252767. doi: 10.1124/jpet.118.252767. [Epub ahead of print]

2.

Physical interaction of junctophilin and the CaV1.1 C terminus is crucial for skeletal muscle contraction.

Nakada T, Kashihara T, Komatsu M, Kojima K, Takeshita T, Yamada M.

Proc Natl Acad Sci U S A. 2018 Apr 24;115(17):4507-4512. doi: 10.1073/pnas.1716649115. Epub 2018 Apr 9.

3.

Long-term Results of External Beam Radiotherapy for Prostate Cancer with Prostate-specific Antigen of More Than 50 ng/ml and Without Evidence of Lymph Node or Distant Metastasis.

Umezawa R, Inaba K, Nakamura S, Wakita A, Okamoto H, Shima S, Tsuchida K, Kashihara T, Kobayashi K, Harada K, Takahashi K, Murakami N, Ito Y, Igaki H, Jingu K, Itami J.

Anticancer Res. 2018 Apr;38(4):2303-2309.

PMID:
29599353
4.

Importance of the site of positive surgical margin in salvage external beam radiation therapy for biochemical recurrence of prostate cancer after radical prostatectomy.

Kashihara T, Nakamura S, Wakita A, Okamoto H, Inaba K, Umezawa R, Shima S, Tsuchida K, Kobayashi K, Takahashi K, Murakami N, Ito Y, Igaki H, Fujimoto H, Uno T, Itami J.

Cancer Med. 2018 May;7(5):1723-1730. doi: 10.1002/cam4.1408. Epub 2018 Mar 23.

5.

PDGF-induced migration of synthetic vascular smooth muscle cells through c-Src-activated L-type Ca2+ channels with full-length CaV1.2 C-terminus.

Guo X, Kashihara T, Nakada T, Aoyama T, Yamada M.

Pflugers Arch. 2018 Jun;470(6):909-921. doi: 10.1007/s00424-018-2114-3. Epub 2018 Feb 13.

PMID:
29441404
6.

Image-guided interstitial high-dose-rate brachytherapy for locally recurrent uterine cervical cancer: A single-institution study.

Umezawa R, Murakami N, Nakamura S, Wakita A, Okamoto H, Tsuchida K, Kashihara T, Kobayashi K, Harada K, Takahashi K, Inaba K, Ito Y, Igaki H, Masui K, Yoshida K, Jingu K, Tselis N, Itami J.

Brachytherapy. 2018 Mar - Apr;17(2):368-376. doi: 10.1016/j.brachy.2017.11.011. Epub 2017 Dec 21.

PMID:
29275869
7.

Crucial role of 4-deoxy-L-erythro-5-hexoseulose uronate reductase for alginate utilization revealed by adaptive evolution in engineered Saccharomyces cerevisiae.

Matsuoka F, Hirayama M, Kashihara T, Tanaka H, Hashimoto W, Murata K, Kawai S.

Sci Rep. 2017 Jun 23;7(1):4206. doi: 10.1038/s41598-017-04481-3.

8.

Improvement of lipid production by the oleaginous yeast Rhodosporidium toruloides through UV mutagenesis.

Yamada R, Kashihara T, Ogino H.

World J Microbiol Biotechnol. 2017 May;33(5):99. doi: 10.1007/s11274-017-2269-7. Epub 2017 Apr 20.

PMID:
28429279
9.

Angiotensin II activates CaV 1.2 Ca2+ channels through β-arrestin2 and casein kinase 2 in mouse immature cardiomyocytes.

Kashihara T, Nakada T, Kojima K, Takeshita T, Yamada M.

J Physiol. 2017 Jul 1;595(13):4207-4225. doi: 10.1113/JP273883. Epub 2017 Apr 20.

10.

The role of interstitial brachytherapy in the management of primary radiation therapy for uterine cervical cancer.

Murakami N, Kobayashi K, Kato T, Nakamura S, Wakita A, Okamoto H, Shima S, Tsuchida K, Kashihara T, Harada K, Takahashi K, Umezawa R, Inaba K, Ito Y, Igaki H, Itami J.

J Contemp Brachytherapy. 2016 Oct;8(5):391-398. Epub 2016 Oct 10.

11.

Long-term observations of radiation-induced creatinine clearance reduction and renal parenchymal volume atrophy.

Inaba K, Okamoto H, Wakita A, Tsuchida K, Kashihara T, Kobayashi K, Harada K, Kitaguchi M, Sekii S, Umezawa R, Takahashi K, Murakami N, Ito Y, Igaki H, Uno T, Itami J.

Radiother Oncol. 2016 Jul;120(1):145-9. doi: 10.1016/j.radonc.2016.04.022. Epub 2016 Jun 29.

PMID:
27372224
12.

Erratum: A total EQD2 greater than 85 Gy for trachea and main bronchus D2cc being associated with severe late complications after definitive endobronchial brachytherapy.

Murakami N, Kobayashi K, Nakamura S, Wakita A, Okamoto H, Tsuchida K, Kashihara T, Harada K, Yamada M, Sekii S, Takahashi K, Umezawa R, Inaba K, Ito Y, Igaki H, Itami J.

J Contemp Brachytherapy. 2016 Apr;8(2):164. doi: 10.5114/jcb.2016.59694. Epub 2016 Apr 29.

13.

Salvage High-dose-rate Interstitial Brachytherapy for Pelvic Recurrent Cervical Carcinoma After Hysterectomy.

Murakami N, Kato T, Miyamoto Y, Nakamura S, Wakita A, Okamoto H, Tsuchida K, Kashihara T, Kobayashi K, Harada K, Kitaguchi M, Sekii S, Takahashi K, Umezawa R, Inaba K, Ito Y, Igaki H, Itami J.

Anticancer Res. 2016 May;36(5):2413-21.

PMID:
27127151
14.

Patterns of recurrence after selective postoperative radiation therapy for patients with head and neck squamous cell carcinoma.

Murakami N, Matsumoto F, Yoshimoto S, Ito Y, Mori T, Ueno T, Tuchida K, Kashihara T, Kobayashi K, Harada K, Kitaguchi M, Sekii S, Umezawa R, Takahashi K, Inaba K, Igaki H, Itami J.

BMC Cancer. 2016 Mar 7;16:192. doi: 10.1186/s12885-016-2229-x.

15.

A phase 1/2 study of carfilzomib in Japanese patients with relapsed and/or refractory multiple myeloma.

Watanabe T, Tobinai K, Matsumoto M, Suzuki K, Sunami K, Ishida T, Ando K, Chou T, Ozaki S, Taniwaki M, Uike N, Shibayama H, Hatake K, Izutsu K, Ishikawa T, Shumiya Y, Kashihara T, Iida S.

Br J Haematol. 2016 Mar;172(5):745-56. doi: 10.1111/bjh.13900. Epub 2016 Jan 5.

16.

Early-onset dropped head syndrome after radiotherapy for head and neck cancer: dose constraints for neck extensor muscles.

Inaba K, Nakamura S, Okamoto H, Kashihara T, Kobayashi K, Harada K, Kitaguchi M, Sekii S, Takahashi K, Murakami N, Ito Y, Igaki H, Uno T, Itami J.

J Radiat Res. 2016 Mar;57(2):169-73. doi: 10.1093/jrr/rrv055. Epub 2015 Dec 18.

17.

A total EQD2 greater than 85 Gy for trachea and main bronchus D2cc being associated with severe late complications after definitive endobronchial brachytherapy.

Murakami N, Kobayashi K, Nakamura S, Wakita A, Okamoto H, Tsuchida K, Kashihara T, Harada K, Yamada M, Sekii S, Takahashi K, Umezawa R, Inaba K, Ito Y, Igaki H, Itami J.

J Contemp Brachytherapy. 2015 Oct;7(5):363-8. doi: 10.5114/jcb.2015.54968. Epub 2015 Oct 13. Erratum in: J Contemp Brachytherapy. 2016 Apr;8(2):164.

18.

Transplantation of adipose tissue-derived stem cells improves cardiac contractile function and electrical stability in a rat myocardial infarction model.

Gautam M, Fujita D, Kimura K, Ichikawa H, Izawa A, Hirose M, Kashihara T, Yamada M, Takahashi M, Ikeda U, Shiba Y.

J Mol Cell Cardiol. 2015 Apr;81:139-49. doi: 10.1016/j.yjmcc.2015.02.012. Epub 2015 Feb 24.

PMID:
25724725
19.

Cardiac overexpression of constitutively active Galpha q causes angiotensin II type1 receptor activation, leading to progressive heart failure and ventricular arrhythmias in transgenic mice.

Matsushita N, Kashihara T, Shimojo H, Suzuki S, Nakada T, Takeishi Y, Mende U, Taira E, Yamada M, Sanbe A, Hirose M.

PLoS One. 2014 Aug 29;9(8):e106354. doi: 10.1371/journal.pone.0106354. eCollection 2014.

20.

Phlorizin prevents electrically-induced ventricular tachyarrhythmia during ischemia in langendorff-perfused guinea-pig hearts.

Hirose M, Shibazaki T, Nakada T, Kashihara T, Yano S, Okamoto Y, Isaji M, Matsushita N, Taira E, Yamada M.

Biol Pharm Bull. 2014;37(7):1168-76.

21.

β(2)-Adrenergic and M(2)-muscarinic receptors decrease basal t-tubular L-type Ca2+ channel activity and suppress ventricular contractility in heart failure.

Kashihara T, Hirose M, Shimojo H, Nakada T, Gomi S, Hongo M, Yamada M.

Eur J Pharmacol. 2014 Feb 5;724:122-31. doi: 10.1016/j.ejphar.2013.12.037. Epub 2013 Dec 31.

PMID:
24389135
22.

Novel regulation of cardiac metabolism and homeostasis by the adrenomedullin-receptor activity-modifying protein 2 system.

Yoshizawa T, Sakurai T, Kamiyoshi A, Ichikawa-Shindo Y, Kawate H, Iesato Y, Koyama T, Uetake R, Yang L, Yamauchi A, Tanaka M, Toriyama Y, Igarashi K, Nakada T, Kashihara T, Yamada M, Kawakami H, Nakanishi H, Taguchi R, Nakanishi T, Akazawa H, Shindo T.

Hypertension. 2013 Feb;61(2):341-51. doi: 10.1161/HYPERTENSIONAHA.111.00647. Epub 2013 Jan 7.

PMID:
23297372
23.

Nicorandil prevents Gαq-induced progressive heart failure and ventricular arrhythmias in transgenic mice.

Hirose M, Takeishi Y, Nakada T, Shimojo H, Kashihara T, Nishio A, Suzuki S, Mende U, Matsumoto K, Matsushita N, Taira E, Sato F, Yamada M.

PLoS One. 2012;7(12):e52667. doi: 10.1371/journal.pone.0052667. Epub 2012 Dec 20.

24.

The proximal C-terminus of α(1C) subunits is necessary for junctional membrane targeting of cardiac L-type calcium channels.

Nakada T, Flucher BE, Kashihara T, Sheng X, Shibazaki T, Horiuchi-Hirose M, Gomi S, Hirose M, Yamada M.

Biochem J. 2012 Dec 1;448(2):221-31. doi: 10.1042/BJ20120773.

PMID:
22928916
25.

Two mechanistically distinct effects of dihydropyridine nifedipine on CaV1.2 L-type Ca²⁺ channels revealed by Timothy syndrome mutation.

Sheng X, Nakada T, Kobayashi M, Kashihara T, Shibazaki T, Horiuchi-Hirose M, Gomi S, Hirose M, Aoyama T, Yamada M.

Eur J Pharmacol. 2012 Jun 15;685(1-3):15-23. doi: 10.1016/j.ejphar.2012.04.029. Epub 2012 Apr 23.

PMID:
22554770
26.

Chronic receptor-mediated activation of Gi/o proteins alters basal t-tubular and sarcolemmal L-type Ca²⁺ channel activity through phosphatases in heart failure.

Kashihara T, Nakada T, Shimojo H, Horiuchi-Hirose M, Gomi S, Shibazaki T, Sheng X, Hirose M, Hongo M, Yamada M.

Am J Physiol Heart Circ Physiol. 2012 Apr 15;302(8):H1645-54. doi: 10.1152/ajpheart.00589.2011. Epub 2012 Feb 3.

27.

Diacylglycerol kinase ζ inhibits ventricular tachyarrhythmias in a mouse model of heart failure.

Hirose M, Takeishi Y, Niizeki T, Nakada T, Shimojo H, Kashihara T, Horiuchi-Hirose M, Kubota I, Mende U, Yamada M.

Circ J. 2011;75(10):2333-42. Epub 2011 Jul 20.

28.

Decrease in the density of t-tubular L-type Ca2+ channel currents in failing ventricular myocytes.

Horiuchi-Hirose M, Kashihara T, Nakada T, Kurebayashi N, Shimojo H, Shibazaki T, Sheng X, Yano S, Hirose M, Hongo M, Sakurai T, Moriizumi T, Ueda H, Yamada M.

Am J Physiol Heart Circ Physiol. 2011 Mar;300(3):H978-88. doi: 10.1152/ajpheart.00508.2010. Epub 2010 Dec 30.

29.

Lupin pyranoisoflavones inhibiting hyphal development in arbuscular mycorrhizal fungi.

Akiyama K, Tanigawa F, Kashihara T, Hayashi H.

Phytochemistry. 2010 Nov;71(16):1865-71. doi: 10.1016/j.phytochem.2010.08.010. Epub 2010 Aug 31.

PMID:
20813384
30.

[Investigation of simplified international diagnostic criteria for autoimmune hepatitis].

Kaneko A, Kubo M, Yamada R, Tanimura T, Yamaguchi D, Yamamoto M, Tatsumi N, Nakama A, Mita E, Kato M, Hijioka T, Oshita M, Ito T, Imanaka K, Katayama K, Sato M, Yoshihara H, Kiriyama K, Imai Y, Kashihara T, Fukui H, Suzuki K, Miyoshi S, Yamada A, Yakushijin T, Mochizuki K, Hiramatsu N, Takehara T, Hayashi N.

Nihon Shokakibyo Gakkai Zasshi. 2010 May;107(5):732-42. Japanese.

PMID:
20460847
31.

[A case of type 4 gastric cancer with peritoneal dissemination complicating venous thromboembolism treated effectively by combination of S-1 and warfarin].

Murayama Y, Sano I, Doi Y, Iwasaki R, Chatani T, Horiki M, Kitada M, Okuno M, Kondo S, Fukuda H, Kashihara T.

Gan To Kagaku Ryoho. 2010 Feb;37(2):311-4. Japanese.

PMID:
20154492
32.

Werner syndrome as a possible cause of non-alcoholic steatohepatitis.

Hashizume H, Sato K, Takagi H, Kanda D, Kashihara T, Kiso S, Mori M.

J Clin Pathol. 2009 Nov;62(11):1043-5. doi: 10.1136/jcp.2009.070680. Epub 2009 Aug 30.

PMID:
19720629
33.

Differential involvement of alpha1-adrenoceptors in vasoconstrictor responses to cooling in mouse plantar arteries in vitro and in vivo.

Kashihara T, Goto K, Sahara Y, Nakayama K, Ishikawa T.

J Smooth Muscle Res. 2009 Jun;45(2-3):87-95.

34.

Role of Na+/Ca2+ exchanger-mediated Ca2+ entry in pressure-induced myogenic constriction in rat posterior cerebral arteries.

Kashihara T, Nakayama K, Matsuda T, Baba A, Ishikawa T.

J Pharmacol Sci. 2009 Jun;110(2):218-22. Epub 2009 Jun 5.

35.

Lamivudine-to-entecavir switching treatment in type B chronic hepatitis patients without evidence of lamivudine resistance.

Kurashige N, Ohkawa K, Hiramatsu N, Yakushijin T, Mochizuki K, Oze T, Kiso S, Kanto T, Takehara T, Kasahara A, Doi Y, Yamada A, Fukuda K, Oshita M, Mita E, Fukui H, Nagase T, Yoshihara H, Imai Y, Kato M, Kashihara T, Hayashi N.

J Gastroenterol. 2009;44(8):864-70. doi: 10.1007/s00535-009-0076-0. Epub 2009 May 28.

PMID:
19475333
36.

Factors contributing to antiviral effect of adefovir dipivoxil therapy added to ongoing lamivudine treatment in patients with lamivudine-resistant chronic hepatitis B.

Kurashige N, Hiramatsu N, Ohkawa K, Yakushijin T, Kiso S, Kanto T, Takehara T, Kasahara A, Doi Y, Yamada A, Oshita M, Mita E, Hagiwara H, Nagase T, Yoshihara H, Hayashi E, Imai Y, Kato M, Kashihara T, Hayashi N.

J Gastroenterol. 2009;44(6):601-7. doi: 10.1007/s00535-009-0038-6. Epub 2009 Apr 22.

PMID:
19387534
37.

Distinct roles of protein kinase C isoforms in myogenic constriction of rat posterior cerebral arteries.

Kashihara T, Nakayama K, Ishikawa T.

J Pharmacol Sci. 2008 Dec;108(4):446-54. Epub 2008 Dec 5.

38.

Differential interplay between protein kinase C and Rho-kinase in the endothelin-1-induced and pressure-induced contractions of rat posterior cerebral artery.

Okamoto Y, Kashihara T, Nonogaki A, Obara K, Nakayama K.

J Cardiovasc Pharmacol. 2004 Nov;44 Suppl 1:S265-7.

PMID:
15838296
39.

Application of an electronic nose system for evaluation of unpleasant odor in coated tablets.

Ohmori S, Ohno Y, Makino T, Kashihara T.

Eur J Pharm Biopharm. 2005 Feb;59(2):289-97.

PMID:
15661501
40.

Development and evaluation of the tablets coated with the novel formulation termed thin-layer sugarless coated tablets.

Ohmori S, Ohno Y, Makino T, Kashihara T.

Int J Pharm. 2004 Jul 8;278(2):459-69.

PMID:
15196649
41.

Characteristics of erythritol and formulation of a novel coating with erythritol termed thin-layer sugarless coating.

Ohmori S, Ohno Y, Makino T, Kashihara T.

Int J Pharm. 2004 Jul 8;278(2):447-57.

PMID:
15196648
42.

Effect of moisture on impact toughness of sugar-coated tablets manufactured by the dusting method.

Ohmori S, Ohno Y, Makino T, Kashihara T.

Chem Pharm Bull (Tokyo). 2004 Mar;52(3):329-34.

43.

Improvement of impact toughness of sugar-coated tablets manufactured by the dusting method.

Ohmori S, Ohno Y, Makino T, Kashihara T.

Chem Pharm Bull (Tokyo). 2004 Mar;52(3):322-8.

44.

A patient with thymoma and four different organ-specific autoimmune diseases.

Asakawa H, Kashihara T, Fukuda H, Yamamoto M.

Neth J Med. 2002 Aug;60(7):292-5.

45.

Gastric T-cell lymphoma presenting with epithelioid granulomas mimicking tuberculosis in regional lymph nodes.

Asakawa H, Tsuji M, Tokumine Y, Kashihara T, Okuno M, Takenaka R, Kawakami F.

J Gastroenterol. 2001 Mar;36(3):190-4.

PMID:
11291883
46.

An increased number of CD40-high monocytes in patients with Crohn's disease.

Sawada-Hase N, Kiyohara T, Miyagawa J, Ueyama H, Nishibayashi H, Murayama Y, Kashihara T, Nakahara M, Miyazaki Y, Kanayama S, Nezu R, Shinomura Y, Matsuzawa Y.

Am J Gastroenterol. 2000 Jun;95(6):1516-23.

PMID:
10894589
47.

Changes in serum hepatic fibrosis markers in biochemical responders to interferon therapy for chronic hepatitis C.

Fukuzaki T, Kawata S, Imai Y, Tamura S, Inada M, Maeda H, Shirai Y, Maeda Y, Yabuuchi I I, Kiriyama K, Himeno S, Toyoshima H, Nishikawa M, Kashihara T, Minami Y, Nishiuchi M, Seki K, Matsuzawa Y.

Hepatol Res. 2000 May;17(2):156-166.

PMID:
10707009
48.

Primary hepatic leiomyosarcoma in a patient with hepatitis C virus-related liver cirrhosis.

Tsuji M, Takenaka R, Kashihara T, Hadama T, Terada N, Mori H.

Pathol Int. 2000 Jan;50(1):41-7.

PMID:
10692176
50.

Intrahepatic cholangiocarcinoma with increased serum CYFRA 21-1 level.

Kashihara T, Ohki A, Kobayashi T, Sato T, Nishizawa H, Ogawa K, Tako H, Kawakami F, Tsuji M, Tamaoka K.

J Gastroenterol. 1998 Jun;33(3):447-53.

PMID:
9658330

Supplemental Content

Loading ...
Support Center